ASO-Based PKM Splice-Switching Therapy Inhibits Hepatocellular Carcinoma Growth
Wai Kit(Rosatom (Russia)), Adrian R. Krainer(Cold Spring Harbor Laboratory)
Cited by 116
Related Papers
Splicing Factor SRSF1 Promotes Pancreatitis and KRASG12D-Mediated Pancreatic Cancer
|Cancer Discovery|2023|65
Gene-specific nonsense-mediated mRNA decay targeting for cystic fibrosis therapy
|Nature Communications|2022|40
Antisense oligonucleotide therapy for H3.3K27M diffuse midline glioma
|Science Translational Medicine|2023|28
PKM splice-switching ASOs induce upregulation of dual-specificity phosphatases and dephosphorylation of ERK1/2 in hepatocellular carcinoma
|Journal of Biological Chemistry|2025|6
Splice-switching ASOs targeting an Alu-derived exon in the <i>AURKA</i> 5’UTR collapse an SRSF1-AURKA-MYC oncogenic circuit in pancreatic cancer
|bioRxiv (Cold Spring Harbor Laboratory)|2025|0